ReviveMed's technology uses artificial intelligence-based analysis of metabolomics data for drug discovery and development.
The companies will integrate Agilent's Seahorse XFe96/XFe24 Analyzers with BioTek's Cytation 1 Cell Imaging Multi-Mode Reader.
In PNAS this week: genetic diversity of MERS in African camels, centromere evolution in Cryptococcus, and more.
The companies will offer a system for the identification and quantitation of metabolites in biological samples.
In PLOS this week: metabolite profiles of typhoid fever, shifts in cell-free DNA levels following exercise, and more.
The researchers found multiple enzymes that indicate causes of dysregulated adaptive immunity and tissue damage in fatal Ebola virus disease.
Bioage Labs now intends to set up an internal laboratory to experiment with different compounds, while building out its team.
In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.
Investigators are searching for non-invasive biomarkers of rejection and earlier stage graft injury in children and adults who have received kidney transplants.
Researchers reported on results for more than 100 healthy individuals who were tracked with 'omics and clinical tests over nine months.
NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.
Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.
A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.
In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.